WATTS RYAN J. (President and CEO) sold 10.6% of their position (35.20K shares) of DENALI THERAPEUTICS INC. on the open market
Open‑market sale worth $580.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/8/2026ACC: 0001724310-26-000004
DirectorOfficer· President and CEO
Since Aug 2018
-35.20K
Net shares
Net seller
$580.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
35.20K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−35.20K
Price / share
$16.50
Trade value
$580.77K
% of position
10.6%
1/6/2026
332.03K→296.83K
Total
Net shares
−35.20K
Net value
-$580.77K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/6/2026 | S · Sale | −35.20K | $16.50 | $580.77K | 10.6% | 332.03K | 296.83K |
| Total | −35.20K | -$580.77K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2.15M
Total
2.15M indirect2.15M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.15M | Indirect |
| Total | 2.15M | 2.15M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported